Cargando…
The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer
Aside from its well-known nuclear routes of signaling, estrogen also mediates its effects through cytoplasmic signaling. Estrogen signaling involves numerous posttranslational modifications of its receptor ERα, the best known being phosphorylation. Our research group previously showed that upon estr...
Autores principales: | Choucair, Ali, Pham, Thuy Ha, Omarjee, Soleilmane, Jacquemetton, Julien, Kassem, Loay, Trédan, Olivier, Rambaud, Juliette, Marangoni, Elisabetta, Corbo, Laura, Treilleux, Isabelle, Le Romancer, Muriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755991/ https://www.ncbi.nlm.nih.gov/pubmed/30692633 http://dx.doi.org/10.1038/s41388-019-0694-9 |
Ejemplares similares
-
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα
(+) breast cancer
por: Poulard, Coralie, et al.
Publicado: (2023) -
ERα-36 regulates progesterone receptor activity in breast cancer
por: Konan, Henri-Philippe, et al.
Publicado: (2020) -
Role of JMJD6 in Breast Tumourigenesis
por: Poulard, Coralie, et al.
Publicado: (2015) -
PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer
por: Malbeteau, Lucie, et al.
Publicado: (2022) -
The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer
por: Omarjee, S, et al.
Publicado: (2017)